Top 100 most promising companies in USA by Silicon.
Leverage KOL Sentiment Analysis for Strategic Action
Single platform for Medical and Marketing teams with strict compliance firewalls.
Smooth Slow Scroll with Pause
Top 100 most promising companies in USA by Silicon.
Leverage KOL Sentiment Analysis for Strategic Action.
Single platform for Medical and Marketing teams with strict compliance firewalls.
Book a Demo
By /

Transform HCP Insights into Impact - A Masterclass with Industry Leaders

Shaping The Future Of KEE Engagement

  • 06/12/2025
  • 12:00 PM EST
  • Online
Register

Webinar Speakers

Robin L. Winter Sperry

President
Scientific Resilience

Read Bio

Stephanie Otis

Vice President of US medical Affairs
Ferring Pharmaceuticals

Read Bio

Badal Shah

Founder and President Neolytica
(Moderator)

Read Bio

About Webinar

Transform HCP insights into Impact- A Masterclass with Industry leaders is a webinar series crafted to bring together prominent thought leaders and experts to explore the transformative topics that are shaping the Key External Expert (KEE) engagement insights generating impact measurement and precision communication between pharma and HCPs. Our goal is to provide valuable insights, foster discussion, and drive innovation within the sector.
This session will delve into the dynamic landscape of KEE  strategic engagement, exploring the latest trends, challenges, and opportunities. We anticipate a rich discussion covering a range of topics, including:
•Evolving Landscape of Medical Communication: Examining the changing role of KEE s in the digital age and the impact of social media, online platforms, and other communication channels.
•The Future of KEE Engagement: Forecasting emerging trends and technologies like AI that will shape the future of KEE interactions, such as virtual engagement, personalized communication, and data-driven insights.
We look forward to having you attend the event!
Register for the Webinar

For future Webinar & Event updates subscribe to our newsletter.

Neolytica Logo | KOL

QUICK LINKS

SOLUTIONS

PRODUCTS

Get in Touch

Scroll to Top

Robin L. Winter-Sperry, MD

Robin Winter-Sperry, MD, is a pioneer in advancing global medical affairs and field-based medical excellence. As President of Scientific Resilience, she leads strategy and innovation in medical affairs consulting. She has held senior roles at Pfizer, Ipsen, and Sanofi Genzyme, where she built global standards for field-based medical operations.

Robin has been instrumental in shaping the role of Medical Science Liaisons (MSLs) across the biopharmaceutical industry. At Novartis, she established the company’s first doctoral-level MSL department, setting a benchmark for the industry. She also founded Scientific Advantage, a consulting firm known for transforming medical affairs strategies and organizations.

She currently serves as President of the Americas and Board Member of the Medical Affairs Professional Society (MAPS), having previously chaired its Membership Experience Committee and founded multiple FAWGs. Her work has significantly impacted product launches, lifecycle management, and field medical innovation globally.

Stephanie Otis

Stephanie Otis is the Vice President of US Medical Affairs at Ferring Pharmaceuticals, where she leads strategic initiatives across reproductive medicine, uro-oncology, gastroenterology, and orthopaedics. She oversees a cross-functional team of experts in medical strategy, field engagement, real-world evidence, and scientific communications.

With a background spanning roles in Medical Affairs, Commercial Operations, and Healthcare Compliance, Stephanie brings a comprehensive perspective to delivering medical excellence. Prior to Ferring, she held leadership positions at Berlex Labs and Bayer Healthcare, contributing to key areas such as pharmacovigilance, medical education, and information services.

She is Chairperson of Ferring’s Women Council and a recognized Rising Star by the Healthcare Business Women’s Association. Stephanie holds a Doctorate in Pharmacy and a graduate degree in Healthcare Compliance, and is a strong advocate for advancing women in leadership across the life sciences industry.

Badal Shah

Badal Shah has transformed the approach to affecting successful outcomes inside the arena of thought leadership within health and life sciences. It was his vision to start a subsidiary company completely focused on Data analytics and Artificial intelligence. He will be the Managing Director of Neolytica and responsible for its growth and P&L.

  • Recognized as “Top 100 Healthcare leaders” by International Forum on Advancement in Healthcare (IFAH) and was also nominated for “Forbes 30 under 30” in Healthcare in 2018.
  • Pioneered the innovative approach of “How to achieve effective medical communication and optimize field force during pre and post drug launches” supporting numerous successful drug launches.
  • He was also part of the team to establish KOL mapping business at Veeva systems, before joining QPharma.